Patents Assigned to ROXIANT APS
  • Viral vector suitable for gene therapy encoding a variant of a BPIFB4 protein
    Patent number: 11208447
    Abstract: The present invention relates inter alia to a polynucleotide or viral vector encoding a variant of BPIFB4 (Bactericidal/Permeability Increasing protein family B, member 4) protein and to their use for the treatment of pathologies involving impairment of nitric oxide signalling.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: December 28, 2021
    Assignee: ROXIANT APS
    Inventors: Annibale Alessandro Puca, Carmine Vecchione